Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Crohn's Disease
Crohn's Disease
Celgene's Crohn's Disease Drug Candidate Highlighted in NEJM
TheStreet.com
Thu, 03/19/15 - 08:07 am
Celgene
Crohn's Disease
Mongersen
New England Journal of Medicine
FDA postpones key hearing on biosimilar copy of blockbuster drug
Yahoo/Reuters
Thu, 02/26/15 - 09:55 am
FDA
biosimilars
Rensima
Remicade
JNJ
rheumatoid arthritis
Crohn's Disease
Hospira
Celltrion
Celgene Crohn's drug trial successful
Yahoo/Investors Business Daily
Tue, 10/21/14 - 08:02 am
Celgene
Crohn's Disease
Mongersen
First Detailed Look at Celgene Crohn's Disease Pill Impresses
TheStreet.com
Mon, 10/20/14 - 10:55 am
Celgene
Crohn's Disease
GED-0301
Was Celgene's Crohn's Disease Drug Worth The Price?
Investors.com
Thu, 10/16/14 - 07:48 am
Celgene
Crohn's Disease
GED-0301
Safety Worries Over Celgene's Experimental Crohn's Drug Overblown
TheStreet.com
Wed, 09/17/14 - 08:41 am
Celgene
Crohn's Disease
GED-301
New biotherapeutics drug for Crohn's to enter trials
Pharmaphorum
Wed, 09/3/14 - 08:17 am
Crohn's Disease
IBS
Blautix
Thetanix
4D Pharma
Takeda’s Bowel Disease Drug Approved by U.S. Regulators
Bloomberg
Wed, 05/21/14 - 10:26 am
Takeda
FDA
Entyvio
vedolizumab
ulcerative colitis
Crohn's Disease
Celgene enters deal potentially worth over $2.5 billion for Nogra Pharma's Crohn's disease drug
First Word Pharma
Thu, 04/24/14 - 11:36 am
Celgene
Nogra Pharma
Crohn's Disease
GED-0301
Takeda gets positive CHMP opinion for Entyvio for UC and Crohn’s disease
The Pharma Letter
Sat, 03/22/14 - 12:46 pm
Takeda
vedolizumab
Entyvio
ulcerative colitis
Crohn's Disease
AstraZeneca, Amgen Crohn's drug runs into PhII 'logistical' snafu
Fierce Biotech
Thu, 10/17/13 - 10:57 am
Amgen
Crohn's Disease
AMG 181
AstraZeneca
Coronado's inflammatory bowel disease treatment fails mid-stage study
Reuters
Mon, 10/14/13 - 08:54 am
Coronado Biosciences
Crohn's Disease
TSO
The Impact of a Failed Crohn's Disease Trial Study
Motley Fool
Fri, 08/30/13 - 10:36 am
Crohn's Disease
Vercirnon
ChemoCentryx
GSK
GSK's Crohn's disease treatment fails in Phase III trial
Reuters
Fri, 08/23/13 - 11:11 am
GSK
Crohn's Disease
ChemoCentryx
Vercirnon
Coronado Biosciences Reuniting Old Friends
Seeking Alpha
Fri, 07/5/13 - 10:40 am
Coronado Biosciences
CNDO-201
CNDO-109
Crohn's Disease
Multiple Myeloma
acute myeloid leukemia
[video]AbbVie's New Crohn's Disease Drug Candidate
Motley Fool
Tue, 05/21/13 - 10:06 am
AbbVie
Crohn's Disease
JAK inhibitors
Galapagos
AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease
Yahoo/Reuters
Fri, 05/17/13 - 10:43 am
Galapagos
AbbVie
GLPG0634
Crohn's Disease
Coronado Biosciences: Provides Investors With 2 Distinct Pipelines And Significant Market Potential
Seeking Alpha
Sun, 04/1/12 - 12:18 pm
Coronado Biosciences
Crohn's Disease
ulcerative colitis
multiple sclerosis
OvaMed
CNDO-109
acute myeloid leukemia
Coronado Biosciences reports Phase 1 clinical trial results for TSO in Crohn's
Yahoo/Fly on the Wall
Tue, 02/28/12 - 10:57 am
Coronado Biosciences
TSO
Crohn's Disease
Abbott’s Freyman Says Humira Gained Market Share in Crohn’s, Psoriasis
Bloomberg
Wed, 07/20/11 - 12:50 pm
Crohn's Disease
psoriasis
Abbott Laboratories
Humira
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »